array:23 [
  "pii" => "S2173574318301424"
  "issn" => "21735743"
  "doi" => "10.1016/j.reumae.2018.08.003"
  "estado" => "S300"
  "fechaPublicacion" => "2018-11-01"
  "aid" => "100000"
  "copyright" => "Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología"
  "copyrightAnyo" => "2018"
  "documento" => "article"
  "crossmark" => 1
  "subdocumento" => "sco"
  "cita" => "Reumatol Clin. 2018;14:317-9"
  "abierto" => array:3 [
    "ES" => false
    "ES2" => false
    "LATM" => false
  ]
  "gratuito" => false
  "lecturas" => array:2 [
    "total" => 10
    "formatos" => array:2 [
      "HTML" => 6
      "PDF" => 4
    ]
  ]
  "Traduccion" => array:1 [
    "es" => array:19 [
      "pii" => "S1699258X18301840"
      "issn" => "1699258X"
      "doi" => "10.1016/j.reuma.2018.08.004"
      "estado" => "S300"
      "fechaPublicacion" => "2018-11-01"
      "aid" => "1266"
      "copyright" => "Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología"
      "documento" => "article"
      "crossmark" => 1
      "subdocumento" => "sco"
      "cita" => "Reumatol Clin. 2018;14:317-9"
      "abierto" => array:3 [
        "ES" => true
        "ES2" => true
        "LATM" => true
      ]
      "gratuito" => true
      "lecturas" => array:2 [
        "total" => 2629
        "formatos" => array:3 [
          "EPUB" => 78
          "HTML" => 2076
          "PDF" => 475
        ]
      ]
      "es" => array:10 [
        "idiomaDefecto" => true
        "cabecera" => "<span class="elsevierStyleTextfn">Editorial</span>"
        "titulo" => "Ni los anticuerpos antinucleares ni los anticuerpos dirigidos contra ant&#237;genos extra&#237;bles del n&#250;cleo son lo que sol&#237;an ser&#46; Un futuro cambio de nomenclatura y recomendaciones para su determinaci&#243;n en pr&#225;ctica cl&#237;nica habitual"
        "tienePdf" => "es"
        "tieneTextoCompleto" => "es"
        "paginas" => array:1 [
          0 => array:2 [
            "paginaInicial" => "317"
            "paginaFinal" => "319"
          ]
        ]
        "titulosAlternativos" => array:1 [
          "en" => array:1 [
            "titulo" => "Neither the anti-nuclear antibodies nor the anti-extractable nuclear antigens Are What They Used to Be&#46; A Future Change of Nomenclature"
          ]
        ]
        "contieneTextoCompleto" => array:1 [
          "es" => true
        ]
        "contienePdf" => array:1 [
          "es" => true
        ]
        "autores" => array:1 [
          0 => array:2 [
            "autoresLista" => "Diana Hern&#225;ndez-Fl&#243;rez, Lara Valor"
            "autores" => array:2 [
              0 => array:2 [
                "nombre" => "Diana"
                "apellidos" => "Hern&#225;ndez-Fl&#243;rez"
              ]
              1 => array:2 [
                "nombre" => "Lara"
                "apellidos" => "Valor"
              ]
            ]
          ]
        ]
      ]
      "idiomaDefecto" => "es"
      "Traduccion" => array:1 [
        "en" => array:9 [
          "pii" => "S2173574318301424"
          "doi" => "10.1016/j.reumae.2018.08.003"
          "estado" => "S300"
          "subdocumento" => ""
          "abierto" => array:3 [
            "ES" => false
            "ES2" => false
            "LATM" => false
          ]
          "gratuito" => false
          "lecturas" => array:1 [
            "total" => 0
          ]
          "idiomaDefecto" => "en"
          "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173574318301424?idApp=UINPBA00004M"
        ]
      ]
      "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1699258X18301840?idApp=UINPBA00004M"
      "url" => "/1699258X/0000001400000006/v2_201812110614/S1699258X18301840/v2_201812110614/es/main.assets"
    ]
  ]
  "itemSiguiente" => array:19 [
    "pii" => "S2173574318301205"
    "issn" => "21735743"
    "doi" => "10.1016/j.reumae.2017.08.004"
    "estado" => "S300"
    "fechaPublicacion" => "2018-11-01"
    "aid" => "1121"
    "copyright" => "Elsevier Espa&#241;a&#44; S&#46;L&#46;U&#46; and Sociedad Espa&#241;ola de Reumatolog&#237;a y Colegio Mexicano de Reumatolog&#237;a"
    "documento" => "article"
    "crossmark" => 1
    "subdocumento" => "fla"
    "cita" => "Reumatol Clin. 2018;14:320-33"
    "abierto" => array:3 [
      "ES" => false
      "ES2" => false
      "LATM" => false
    ]
    "gratuito" => false
    "lecturas" => array:2 [
      "total" => 7
      "formatos" => array:2 [
        "HTML" => 3
        "PDF" => 4
      ]
    ]
    "en" => array:13 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Special Article</span>"
      "titulo" => "Recommendations by the Spanish Society of Rheumatology on the Use of Biological Therapies in Axial Spondyloarthritis"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "tieneResumen" => array:2 [
        0 => "en"
        1 => "es"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "320"
          "paginaFinal" => "333"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "Recomendaciones de la Sociedad Espa&#241;ola de Reumatolog&#237;a sobre el uso de terapias biol&#243;gicas en espondiloartritis axial"
        ]
      ]
      "contieneResumen" => array:2 [
        "en" => true
        "es" => true
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:7 [
          "identificador" => "fig0005"
          "etiqueta" => "Fig&#46; 1"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr1.jpeg"
              "Alto" => 1900
              "Ancho" => 3167
              "Tamanyo" => 411728
            ]
          ]
          "descripcion" => array:1 [
            "en" => "<p id="spar0045" class="elsevierStyleSimplePara elsevierViewall">Treatment algorithm for axial spondyloarthritis&#46; ADA&#58; adalimumab&#59; NSAIDS&#58; nonsteroidal anti-inflammatory drugs&#59; anti-IL17&#58; interleukin 17 inhibitor&#59; anti-TNF&#58; tumour necrosis factor inhibitor&#59; ASDAS&#58; ASAS-endorsed disease activity score&#59; BASDAI&#58; Bath Ankylosing Spondylitis Disease Activity Index&#59; DMARDs&#58; disease-modifying antirheumatic drugs&#59; GOL&#58; golimumab&#59; INF&#58; infliximab&#59; LF&#58; leflunomide&#59; MTX&#58; methotrexate&#59; SSZ&#58; sulfasalazine&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Jordi Gratac&#243;s, Petra D&#237;az del Campo Fontecha, Cristina Fern&#225;ndez-Carballido, Xavier Juanola Roura, Luis Francisco Linares Ferrando, Eugenio de Miguel Mendieta, Santiago Mu&#241;oz Fern&#225;ndez, Jose Luis Rosales-Alexander, Pedro Zarco Montejo, Mercedes Guerra Rodr&#237;guez, Victoria Navarro Comp&#225;n"
          "autores" => array:11 [
            0 => array:2 [
              "nombre" => "Jordi"
              "apellidos" => "Gratac&#243;s"
            ]
            1 => array:2 [
              "nombre" => "Petra"
              "apellidos" => "D&#237;az del Campo Fontecha"
            ]
            2 => array:2 [
              "nombre" => "Cristina"
              "apellidos" => "Fern&#225;ndez-Carballido"
            ]
            3 => array:2 [
              "nombre" => "Xavier"
              "apellidos" => "Juanola Roura"
            ]
            4 => array:2 [
              "nombre" => "Luis Francisco"
              "apellidos" => "Linares Ferrando"
            ]
            5 => array:2 [
              "nombre" => "Eugenio"
              "apellidos" => "de Miguel Mendieta"
            ]
            6 => array:2 [
              "nombre" => "Santiago"
              "apellidos" => "Mu&#241;oz Fern&#225;ndez"
            ]
            7 => array:2 [
              "nombre" => "Jose Luis"
              "apellidos" => "Rosales-Alexander"
            ]
            8 => array:2 [
              "nombre" => "Pedro"
              "apellidos" => "Zarco Montejo"
            ]
            9 => array:2 [
              "nombre" => "Mercedes"
              "apellidos" => "Guerra Rodr&#237;guez"
            ]
            10 => array:2 [
              "nombre" => "Victoria"
              "apellidos" => "Navarro Comp&#225;n"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "es" => array:9 [
        "pii" => "S1699258X17302322"
        "doi" => "10.1016/j.reuma.2017.08.008"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "es"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1699258X17302322?idApp=UINPBA00004M"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173574318301205?idApp=UINPBA00004M"
    "url" => "/21735743/0000001400000006/v1_201810310644/S2173574318301205/v1_201810310644/en/main.assets"
  ]
  "en" => array:14 [
    "idiomaDefecto" => true
    "cabecera" => "<span class="elsevierStyleTextfn">Editorial</span>"
    "titulo" => "Neither the anti-nuclear antibodies nor the anti-extractable nuclear antigens Are What They Used to Be&#46; A Future Change of Nomenclature"
    "tieneTextoCompleto" => true
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "317"
        "paginaFinal" => "319"
      ]
    ]
    "autores" => array:1 [
      0 => array:4 [
        "autoresLista" => "Diana Hern&#225;ndez-Fl&#243;rez, Lara Valor"
        "autores" => array:2 [
          0 => array:3 [
            "nombre" => "Diana"
            "apellidos" => "Hern&#225;ndez-Fl&#243;rez"
            "referencia" => array:2 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
              1 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">b</span>"
                "identificador" => "aff0010"
              ]
            ]
          ]
          1 => array:4 [
            "nombre" => "Lara"
            "apellidos" => "Valor"
            "email" => array:1 [
              0 => "larissa&#46;valormendez&#64;uk-erlangen&#46;de"
            ]
            "referencia" => array:4 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
              1 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">b</span>"
                "identificador" => "aff0010"
              ]
              2 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">c</span>"
                "identificador" => "aff0015"
              ]
              3 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">&#42;</span>"
                "identificador" => "cor0005"
              ]
            ]
          ]
        ]
        "afiliaciones" => array:3 [
          0 => array:3 [
            "entidad" => "Servicio de Reumatolog&#237;a&#44; Hospital General Universitario Gregorio Mara&#241;&#243;n&#44; Madrid&#44; Espa&#241;a"
            "etiqueta" => "a"
            "identificador" => "aff0005"
          ]
          1 => array:3 [
            "entidad" => "Instituto de Investigaci&#243;n Biom&#233;dica del Hospital Gregorio Mara&#241;&#243;n&#44; Madrid&#44; Espa&#241;a"
            "etiqueta" => "b"
            "identificador" => "aff0010"
          ]
          2 => array:3 [
            "entidad" => "Reumatolog&#237;a e Inmunolog&#237;a&#44; Universidad Friedrich-Alexander&#44; Erlangen-N&#252;rmberg&#44; Alemania"
            "etiqueta" => "c"
            "identificador" => "aff0015"
          ]
        ]
        "correspondencia" => array:1 [
          0 => array:3 [
            "identificador" => "cor0005"
            "etiqueta" => "&#8270;"
            "correspondencia" => "Corresponding author&#46;"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "es" => array:1 [
        "titulo" => "Ni los anticuperpos antinucleares ni los anticuerpos dirigidos contra ant&#237;genos extra&#237;bles del n&#250;cleoson lo que sol&#237;an ser&#46; Un futuro cambio de nomenclatura y recomendaciones para su determinaci&#243;n en pr&#225;ctica cl&#237;nica habitual"
      ]
    ]
    "textoCompleto" => "<span class="elsevierStyleSections"><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0005">Antinuclear Antibodies</span><p id="par0005" class="elsevierStylePara elsevierViewall">Antinuclear antibodies &#40;ANA&#41; were described for the first time by Coons and Kaplan&#44;<a class="elsevierStyleCrossRef" href="#bib0085"><span class="elsevierStyleSup">1</span></a> and although it is not indicated by their name&#44; they include autoantibodies &#40;AAb&#41; directed against cytoplasmic structures and the cell wall&#44; which is to say that this is a term sustained by historic reasons for more than 60 years&#46; In the classification of positive ANA staining patterns detected by immunofluorescence &#40;IF&#41;&#44; nuclear patterns are reported as much as cytoplasmic and mitotic patterns&#46;<a class="elsevierStyleCrossRefs" href="#bib0095"><span class="elsevierStyleSup">3&#44;4</span></a></p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0010">Antibodies Directed Against Extractable Nuclear Antigens</span><p id="par0010" class="elsevierStylePara elsevierViewall">Antibodies directed against extractable nuclear antigens &#40;ENA&#41; were described in 1959 by Holman and Robbins&#44;<a class="elsevierStyleCrossRef" href="#bib0105"><span class="elsevierStyleSup">5</span></a> who with the utilization of saline solutions of low ionic strength extracted 4 protein antigens from the nucleus&#58; SSA&#47;Ro60&#44; SSB7La&#44; U1-ribonucleoprotein &#40;RNP&#41; and Smith &#40;Sm&#41;&#46;</p><p id="par0015" class="elsevierStylePara elsevierViewall">Over time&#44; this spectrum has grown and it is possible to detect AAb directed against other cytoplasmic or nuclear antigens and other cell compartments&#44; such as receptors of</p><p id="par0020" class="elsevierStylePara elsevierViewall">lamina B in the nuclear membrane&#44; histones&#44; other RNP and proteins that are expressed only when the cell is in mitosis &#40;Sp100&#44; Ku&#44; Mi-2&#44; cyclin&#44; Scl-70&#44; mitotic spindle&#44; centrioles and kinetochores&#41;&#46; This has benefited the introduction of multiple detection tests that vary depending on the company&#44; according to the technological platform and the AAb to be evaluated&#46;<a class="elsevierStyleCrossRefs" href="#bib0090"><span class="elsevierStyleSup">2&#44;3</span></a> At the present time&#44; AAb detection panels usually include nuclear antigens &#40;double-stranded DNA&#44; ENA&#41; and cytoplasm antigens &#40;ribosomal-P Jo-1&#46; In Spain&#44; there are at least 5 companies that offer platforms for specific antigens &#40;the so-called ENA profile&#41;&#44; which utilize diverse native proteins&#44; purified or human recombinant&#44; such as Ro60 kDa&#44; Ro52 kDa&#44; La&#44; U1-RNP&#44; Sm&#44; histones&#44; centromere-B&#44; Scl-70 and Jo-1&#46;</p></span><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0015">Methodology for the Determination of Antinuclear Antibodies and Antibodies Directed Against Extractable Nuclear Antigens</span><p id="par0025" class="elsevierStylePara elsevierViewall">In the majority of autoimmunity laboratories&#44; both ANA and ENA are detected by IF&#44; utilizing the laryngeal carcinoma Hep-2 cell line or one of its variants &#40;for example&#44; the Hep-2000 cell line&#41;&#44; and report a maximum dilution in which the antigen-antibody reaction is observable&#44; as is the IF staining pattern&#46; It is considered that ANA are positive from a dilution of 1&#58;80 in adults &#40;although some guidelines recommend that a dilution of 1&#58;160 is the inferior limit&#41; and&#44; in pediatrics&#44; they are positive at dilutions starting at 1&#58;10 or 1&#58;20&#46;<a class="elsevierStyleCrossRefs" href="#bib0095"><span class="elsevierStyleSup">3&#44;6&#8211;8</span></a> Subsequently&#44; there is a second determination to evaluate the specificity of AAb using techniques such immunoblotting or enzyme-linked immunosorbent assay &#40;ELISA&#41;&#46; Because of the wide variability among the multiple assay platforms being marketed&#44; it is indispensable to know the antigens that have been evaluated in each determination and information must be given about all of those utilized&#44; whether the results were negative or positive&#46;<a class="elsevierStyleCrossRefs" href="#bib0090"><span class="elsevierStyleSup">2&#44;3&#44;6</span></a></p><p id="par0030" class="elsevierStylePara elsevierViewall">These determination provide us with extremely valuable information&#44; given that AAb can develop years before the clinical manifestations of systemic lupus erythematosus&#44; Sj&#246;gren&#39;s syndrome&#44; scleroderma&#44; mixed connective tissue disease and idiopathic or inflammatory myopathies &#40;IIM&#41;&#46; The findings are potentially relevant in the achievement of the diagnosis and for establishing the prognosis&#44; the different forms of the clinical course and the eventual complications of these diseases&#46;<a class="elsevierStyleCrossRefs" href="#bib0115"><span class="elsevierStyleSup">7&#8211;10</span></a></p></span><span id="sec0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0020">New Autoantibodies and a New Nomenclature&#63;</span><p id="par0035" class="elsevierStylePara elsevierViewall">The use of the nomenclature for ANA and ENA is currently considered imprecise&#59; there are authors who refer to them as AAb directed against specific cell antigens&#44;<a class="elsevierStyleCrossRefs" href="#bib0110"><span class="elsevierStyleSup">6&#8211;8</span></a> and a change in the nomenclature is recommended&#46;<a class="elsevierStyleCrossRef" href="#bib0110"><span class="elsevierStyleSup">6</span></a> The consensus on standardization for the evaluation of AAb was developed by two groups&#58; the European Autoimmunity Standardization Initiative &#40;EASI&#41; and the International Union of Immunologic Societies&#47;World Health Organization&#47;Arthritis Foundation&#47;Centers for Disease Control and Prevention &#40;IUIS&#47;WHO&#47;AF&#47;CDC&#41;&#46; The result is the proposal of a change in the nomenclature and 25 recommendations for the harmonization of clinical and technical aspects of AAb determination&#44; resolve discrepancies in the detection methods and stress the importance of communication between clinical specialists and the laboratory&#46;<a class="elsevierStyleCrossRef" href="#bib0110"><span class="elsevierStyleSup">6</span></a></p><p id="par0040" class="elsevierStylePara elsevierViewall">However&#44; what is the sense of adapting ourselves to employing a new nomenclature when we are at ease with the one we already know&#63; In recent years&#44; we have found that the number of new AAb associated with specific clinical conditions has continued to grow&#44; a fact that means that we must be increasingly accurate when we refer to them&#46; We should stress that some of these new AAb that are specific for IIM&#44; such as anti-MDA5 &#40;anti-melanoma differentiation-associated gene 5&#41; antibodies and anti-HMGCR &#40;anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase&#41;&#44; are not associated with any IF pattern&#46;<a class="elsevierStyleCrossRefs" href="#bib0135"><span class="elsevierStyleSup">11&#44;12</span></a></p><p id="par0045" class="elsevierStylePara elsevierViewall">Anti-Ro antibodies constitute another valid example to illustrate this case&#58; the distinction between Ro52 and Ro60 was not defined until 1988&#44; and they differ in their intracellular localization&#46;<a class="elsevierStyleCrossRef" href="#bib0145"><span class="elsevierStyleSup">13</span></a> Anti-Ro60 antibodies have a fine speckled pattern in IF&#44; whereas anti-Ro52 have no defined nuclear staining pattern<a class="elsevierStyleCrossRef" href="#bib0150"><span class="elsevierStyleSup">14</span></a>&#58; would it not then be more useful&#44; in this case&#44; to say that they are specific antibodies&#63;</p><p id="par0050" class="elsevierStylePara elsevierViewall">On the other hand&#44; the cytoplasmic pattern according to IF is defined like any cytoplasmic staining in HEp-2 cells&#44; regardless of the positive or negative staining of the nuclei or mitotic cells&#44; with 5 main pattern subgroups&#58; 1&#41; fibrillary&#59; 2&#41; speckled&#59; 3&#41; mitochondrial&#47;reticular&#59; 4&#41; polar&#47;Golgi apparatus&#59; and 5&#41; bars&#47;rings&#46; All should be included in the laboratory report&#44; as well as the reactivity observed in the cytoplasm and the recognized cytoplasmic structure&#46;<a class="elsevierStyleCrossRefs" href="#bib0090"><span class="elsevierStyleSup">2&#8211;4</span></a> With this diversity&#44; it may be worthwhile to change the manner in which we refer to AAb rather than to continue to utilize the term ANA&#46;</p></span><span id="sec0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0025">The Special Case of Idiopathic Inflammatory Myopathies&#58; Increasingly More Specific Autoantibodies</span><p id="par0055" class="elsevierStylePara elsevierViewall">The formation of AAb has a cardinal role in the pathogenesis of IIM and they are markers that contribute to the diagnosis&#46; With the relatively recent description of new AAb that are specific for IIM&#44; it has been demonstrated that around 60&#37; of these patients have specific AAb&#44; such as anti-Jo-1&#44; anti-MDA5&#44; anti-HMGCR&#44; anti-Mi-2&#44; anti-TIF1 &#40;transcription intermediary factors-1&#41;&#44; anti-NXP2 &#40;nuclear matrix protein 2&#41;&#44; anti-SAE &#40;small ubiquitin-related modifier &#91;SUMO&#93;-activating enzyme&#41; and anti-SRP &#40;signal recognition particle&#41;&#46; At the present time&#44; it is considered that their detection during early phases would be useful in predicting the clinical course of the disease&#46;<a class="elsevierStyleCrossRefs" href="#bib0135"><span class="elsevierStyleSup">11&#44;12</span></a> It is important to point out that&#44; according to IF&#44; only some of these AAb were associated with a speckled or fine speckled cytoplasmic pattern&#59; others were not detected by means of IF&#44; but they were negative for ANA&#46;</p><p id="par0060" class="elsevierStylePara elsevierViewall">Due to the notable association between these AAb and the different clinical phenotypes&#44; it is postulated that they are important not only for the classifications of IIM&#44; but also as factors implicated in the mechanism that underlies their pathogenesis&#44; such as induction&#44; the perpetuation of muscle damage and the association between autoimmunity and oncogenesis&#46;<a class="elsevierStyleCrossRef" href="#bib0135"><span class="elsevierStyleSup">11</span></a> Among these&#44; anti-MDA5 has been related to certain phenotypes of dermatomyositis &#40;DM&#41;&#44; especially with clinically amyopathic DM and with a higher risk of rapidly progressive acute interstitial lung disease&#46;<a class="elsevierStyleCrossRefs" href="#bib0155"><span class="elsevierStyleSup">15&#44;16</span></a> Anti-MDA5 is mutually exclusive with respect to other representative AAb detected in DM&#44; in myopathy associated with cancer and in polymyositis&#46;<a class="elsevierStyleCrossRefs" href="#bib0135"><span class="elsevierStyleSup">11&#44;12&#44;15&#44;16</span></a></p></span><span id="sec0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0030">Perspectives</span><p id="par0065" class="elsevierStylePara elsevierViewall">It is quite clear that&#44; in the near future&#44; we will continue to utilize the nomenclature to which we are accustomed&#44; but it is worthwhile that we become familiar with the new proposals and adapt ourselves to them&#59; the changes may possibly come from laboratory reports as we advance in the description of new AAb&#46;</p><p id="par0070" class="elsevierStylePara elsevierViewall">Changes in nomenclature is not a new situation in rheumatology&#59; in 2012&#44; we saw that the comprehension of the clinical and pathological characteristics of systemic vasculitis made it necessary to modify existing concepts in the International Chapel Hill Consensus Conference that revised the nomenclature of vasculitides for the purpose of offering a more appropriate nomenclature&#46; We have gradually become adapted to this new nomenclature&#44; and it is now the one we utilize in routine clinical practice&#46;<a class="elsevierStyleCrossRef" href="#bib0165"><span class="elsevierStyleSup">17</span></a></p><p id="par0075" class="elsevierStylePara elsevierViewall">Therefore&#44; if the specificity of an AAb is capable of indicating the road toward a clearer definition of the clinical characteristics&#44; toward the prognosis and the outcome of certain conditions&#44; we should be more specific with the terminology&#46; This&#44; moreover&#44; could facilitate communication between clinicians and laboratory professionals&#44; as well as the design of new and more dynamic diagnostic algorithms&#46;</p></span></span>"
    "textoCompletoSecciones" => array:1 [
      "secciones" => array:8 [
        0 => array:2 [
          "identificador" => "sec0005"
          "titulo" => "Antinuclear Antibodies"
        ]
        1 => array:2 [
          "identificador" => "sec0010"
          "titulo" => "Antibodies Directed Against Extractable Nuclear Antigens"
        ]
        2 => array:2 [
          "identificador" => "sec0015"
          "titulo" => "Methodology for the Determination of Antinuclear Antibodies and Antibodies Directed Against Extractable Nuclear Antigens"
        ]
        3 => array:2 [
          "identificador" => "sec0020"
          "titulo" => "New Autoantibodies and a New Nomenclature&#63;"
        ]
        4 => array:2 [
          "identificador" => "sec0025"
          "titulo" => "The Special Case of Idiopathic Inflammatory Myopathies&#58; Increasingly More Specific Autoantibodies"
        ]
        5 => array:2 [
          "identificador" => "sec0030"
          "titulo" => "Perspectives"
        ]
        6 => array:2 [
          "identificador" => "xack374086"
          "titulo" => "Acknowledgments"
        ]
        7 => array:1 [
          "titulo" => "Bibliograf&#237;a"
        ]
      ]
    ]
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "NotaPie" => array:1 [
      0 => array:2 [
        "etiqueta" => "&#9734;"
        "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Please cite this article as&#58; Hern&#225;ndez-Fl&#243;rez D&#44; Valor L&#46; Ni los anticuperpos antinucleares ni los anticuerpos dirigidos contra ant&#237;genos extra&#237;bles del n&#250;cleoson lo que sol&#237;an ser&#46; Un futuro cambio de nomenclatura y recomendaciones para su determinaci&#243;n en pr&#225;ctica cl&#237;nica habitual&#46; Reumatol Clin&#46; 2018&#59;14&#58;317&#8211;319&#46;</p>"
      ]
    ]
    "bibliografia" => array:2 [
      "titulo" => "Bibliograf&#237;a"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "bibs0015"
          "bibliografiaReferencia" => array:17 [
            0 => array:3 [
              "identificador" => "bib0085"
              "etiqueta" => "1"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Localization of antigen in tissue cells&#59; improvements in a method for the detection of antigen by means of fluorescent antibody"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "A&#46;H&#46; Coons"
                            1 => "M&#46;H&#46; Kaplan"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "J Exp Med&#46;"
                        "fecha" => "1950"
                        "volumen" => "91"
                        "paginaInicial" => "1"
                        "paginaFinal" => "13"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15395569"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib0090"
              "etiqueta" => "2"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "International consensus on ANA patterns &#40;ICAP&#41;&#58; the bumpy road towards a consensus on reporting ANA results"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "J&#46; Damoiseaux"
                            1 => "C&#46;A&#46; von M&#252;hlen"
                            2 => "I&#46; Garcia-de la Torre"
                            3 => "O&#46;G&#46; Carballo"
                            4 => "W&#46; de Melo Cruvinel"
                            5 => "P&#46;L&#46;C&#46; Francescantonio"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1007/s13317-016-0075-0"
                      "Revista" => array:6 [
                        "tituloSerie" => "Auto Immun Highlights&#46;"
                        "fecha" => "2016"
                        "volumen" => "7"
                        "paginaInicial" => "1"
                        "paginaFinal" => "8"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26831867"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib0095"
              "etiqueta" => "3"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Challenges in the standardization of autoantibody testing&#58; a comprehensive review"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "R&#46; Tozzoli"
                            1 => "D&#46; Villalta"
                            2 => "N&#46; Bizzaro"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1007/s12016-016-8579-y"
                      "Revista" => array:6 [
                        "tituloSerie" => "Clin Rev Allergy Immunol&#46;"
                        "fecha" => "2017"
                        "volumen" => "53"
                        "paginaInicial" => "68"
                        "paginaFinal" => "77"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/27498835"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib0100"
              "etiqueta" => "4"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Report of the First International Consensus on Standardized Nomenclature of Antinuclear Antibody HEp-2 Cell Patterns 2014-2015"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "E&#46;K&#46; Chan"
                            1 => "J&#46; Damoiseaux"
                            2 => "O&#46;G&#46; Carballo"
                            3 => "K&#46; Conrad"
                            4 => "W&#46; de Melo Cruvinel"
                            5 => "P&#46;L&#46; Francescantonio"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.3389/fimmu.2015.00412"
                      "Revista" => array:5 [
                        "tituloSerie" => "Front Immunol&#46;"
                        "fecha" => "2015"
                        "volumen" => "6"
                        "paginaInicial" => "412"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26347739"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            4 => array:3 [
              "identificador" => "bib0105"
              "etiqueta" => "5"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Antinuclear antibodies in systemic lupus erythematosus"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "H&#46; Holman"
                            1 => "W&#46; Robbins"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Arthritis Rheum&#46;"
                        "fecha" => "1959"
                        "volumen" => "2"
                        "paginaInicial" => "468"
                        "paginaFinal" => "471"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/14402747"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            5 => array:3 [
              "identificador" => "bib0110"
              "etiqueta" => "6"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "N&#46; Agmon-Levin"
                            1 => "J&#46; Damoiseaux"
                            2 => "C&#46; Kallenberg"
                            3 => "U&#46; Sack"
                            4 => "T&#46; Witte"
                            5 => "M&#46; Herold"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1136/annrheumdis-2013-203863"
                      "Revista" => array:6 [
                        "tituloSerie" => "Ann Rheum Dis&#46;"
                        "fecha" => "2014"
                        "volumen" => "73"
                        "paginaInicial" => "17"
                        "paginaFinal" => "23"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24126457"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            6 => array:3 [
              "identificador" => "bib0115"
              "etiqueta" => "7"
              "referencia" => array:1 [
                0 => array:1 [
                  "referenciaCompleta" => "Wiik AS&#44; Hoier-Madsen M&#44; Forslid J&#44; et al&#46; Antinuclear antibodies&#58; a contemporary nomenclature using HEp-2 cells&#46; J Autoimmun 2010&#59;35&#58;276-90&#46;"
                ]
              ]
            ]
            7 => array:3 [
              "identificador" => "bib0120"
              "etiqueta" => "8"
              "referencia" => array:1 [
                0 => array:1 [
                  "referenciaCompleta" => "Meroni PL&#44; Schur PH&#46; ANA screening&#58; an old test with new recommendations&#46; Ann Rheum Dis&#46; 2010&#59;69&#58;1420-2&#46;"
                ]
              ]
            ]
            8 => array:3 [
              "identificador" => "bib0125"
              "etiqueta" => "9"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Development of autoantibodies before the clinical onset of systemic lupus erythematosus"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "M&#46;R&#46; Arbuckle"
                            1 => "M&#46;T&#46; McClain"
                            2 => "M&#46;V&#46; Rubertone"
                            3 => "R&#46;H&#46; Scofield"
                            4 => "G&#46;J&#46; Dennis"
                            5 => "J&#46;A&#46; James"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1056/NEJMoa021933"
                      "Revista" => array:6 [
                        "tituloSerie" => "N Engl J Med&#46;"
                        "fecha" => "2003"
                        "volumen" => "349"
                        "paginaInicial" => "1526"
                        "paginaFinal" => "1533"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/14561795"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            9 => array:3 [
              "identificador" => "bib0130"
              "etiqueta" => "10"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Autoantibodies predate the onset of systemic lupus erythematosus in northern Sweden"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "C&#46; Eriksson"
                            1 => "H&#46; Kokkonen"
                            2 => "M&#46; Johansson"
                            3 => "G&#46; Hallmans"
                            4 => "G&#46; Wadell"
                            5 => "S&#46; Rantap&#228;&#228;-Dahlqvist"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1186/ar3258"
                      "Revista" => array:5 [
                        "tituloSerie" => "Arthritis Res Ther&#46;"
                        "fecha" => "2011"
                        "volumen" => "13"
                        "paginaInicial" => "R30"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21342502"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            10 => array:3 [
              "identificador" => "bib0135"
              "etiqueta" => "11"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Autoantibodies in myositis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "N&#46; McHugh"
                            1 => "S&#46;L&#46; Tansley"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1038/nrrheum.2018.56"
                      "Revista" => array:6 [
                        "tituloSerie" => "Nat Rev Rheumatol&#46;"
                        "fecha" => "2018"
                        "volumen" => "14"
                        "paginaInicial" => "290"
                        "paginaFinal" => "302"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/29674612"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            11 => array:3 [
              "identificador" => "bib0140"
              "etiqueta" => "12"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Bench to bedside review of myositis autoantibodies"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "B&#46; Palterer"
                            1 => "G&#46; Vitiello"
                            2 => "A&#46; Carraresi"
                            3 => "M&#46;G&#46; Giudizi"
                            4 => "D&#46; Cammelli"
                            5 => "P&#46; Parronchi"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1186/1476-7961-7-5"
                      "Revista" => array:5 [
                        "tituloSerie" => "Clin Mol Allergy&#46;"
                        "fecha" => "2018"
                        "volumen" => "7"
                        "paginaInicial" => "5"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19284628"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            12 => array:3 [
              "identificador" => "bib0145"
              "etiqueta" => "13"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "A 52-kD protein is a novel component of the SS-A&#47;Ro antigenic particle"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "E&#46; Ben-Chetrit"
                            1 => "E&#46;K&#46;L&#46; Chan"
                            2 => "K&#46;F&#46; Sullivan"
                            3 => "E&#46;M&#46; Tan"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "J Exp Med&#46;"
                        "fecha" => "1988"
                        "volumen" => "167"
                        "paginaInicial" => "1560"
                        "paginaFinal" => "1571"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/3367095"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            13 => array:3 [
              "identificador" => "bib0150"
              "etiqueta" => "14"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Autoantibodies to 60kDa SS-A&#47;Ro yield a specific nuclear myriad discrete fine speckled immunofluorescence pattern"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "A&#46; Dellavance"
                            1 => "R&#46;R&#46; Alvarenga"
                            2 => "S&#46;H&#46; Rodrigues"
                            3 => "S&#46;H&#46; Barbosa"
                            4 => "A&#46;C&#46; Camilo"
                            5 => "H&#46;S&#46; Shiguedomi"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.jim.2013.01.006"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Immunol Methods&#46;"
                        "fecha" => "2013"
                        "volumen" => "390"
                        "paginaInicial" => "35"
                        "paginaFinal" => "40"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23357050"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            14 => array:3 [
              "identificador" => "bib0155"
              "etiqueta" => "15"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Prevalence and clinical significance of anti-MDA5 antibodies in European patients with polymyositis&#47;dermatomyositis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "A&#46; Ceribelli"
                            1 => "M&#46; Fredi"
                            2 => "M&#46; Taraborelli"
                            3 => "I&#46; Cavazzana"
                            4 => "A&#46; Tincani"
                            5 => "C&#46; Selmi"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Clin Exp Rheumatol&#46;"
                        "fecha" => "2014"
                        "volumen" => "32"
                        "paginaInicial" => "891"
                        "paginaFinal" => "897"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25151986"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            15 => array:3 [
              "identificador" => "bib0160"
              "etiqueta" => "16"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Anti-MDA5 antibodies in a large Mediterranean population of adults with dermatomyositis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "M&#46; Labrador-Horrillo"
                            1 => "M&#46;A&#46; Martinez"
                            2 => "A&#46; Selva-O&#8217;Callaghan"
                            3 => "E&#46; Trallero-Araguas"
                            4 => "E&#46; Balada"
                            5 => "M&#46; Vilardell-Tarres"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1155/2014/290797"
                      "Revista" => array:5 [
                        "tituloSerie" => "J Immunol Res&#46;"
                        "fecha" => "2014"
                        "volumen" => "2014"
                        "paginaInicial" => "290797"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24741583"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            16 => array:3 [
              "identificador" => "bib0165"
              "etiqueta" => "17"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "J&#46;C&#46; Jennette"
                            1 => "R&#46;J&#46; Falk"
                            2 => "P&#46;A&#46; Bacon"
                            3 => "N&#46; Basu"
                            4 => "M&#46;C&#46; Cid"
                            5 => "F&#46; Ferrario"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1002/art.37715"
                      "Revista" => array:6 [
                        "tituloSerie" => "Arthritis Rheum&#46;"
                        "fecha" => "2013"
                        "volumen" => "65"
                        "paginaInicial" => "1"
                        "paginaFinal" => "11"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23045170"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
    "agradecimientos" => array:1 [
      0 => array:4 [
        "identificador" => "xack374086"
        "titulo" => "Acknowledgments"
        "texto" => "<p id="par0080" class="elsevierStylePara elsevierViewall">The authors wish to thank Dr&#46; Lina Mart&#237;nez-Estupi&#241;&#225;n &#40;Department of Rheumatology&#44; Fundaci&#243;n Jim&#233;nez D&#237;az&#44; Madrid&#41; and Dr&#46; Francisco Javier L&#243;pez-Longo &#40;Department of Rheumatology&#44; Hospital General Universitario Gregorio Mara&#241;&#243;n&#44; Madrid&#41; for their critical reading of this paper and the corrections they proposed&#46;</p>"
        "vista" => "all"
      ]
    ]
  ]
  "idiomaDefecto" => "en"
  "url" => "/21735743/0000001400000006/v1_201810310644/S2173574318301424/v1_201810310644/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "17335"
    "tipo" => "SECCION"
    "es" => array:2 [
      "titulo" => "Editorial"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "es"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/21735743/0000001400000006/v1_201810310644/S2173574318301424/v1_201810310644/en/main.pdf?idApp=UINPBA00004M&text.app=https://reumatologiaclinica.org/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173574318301424?idApp=UINPBA00004M"
]
Share
Journal Information

Statistics

Follow this link to access the full text of the article

Editorial
Neither the anti-nuclear antibodies nor the anti-extractable nuclear antigens Are What They Used to Be. A Future Change of Nomenclature
Ni los anticuperpos antinucleares ni los anticuerpos dirigidos contra antígenos extraíbles del núcleoson lo que solían ser. Un futuro cambio de nomenclatura y recomendaciones para su determinación en práctica clínica habitual
Diana Hernández-Flóreza,b, Lara Valora,b,c,
Corresponding author
a Servicio de Reumatología, Hospital General Universitario Gregorio Marañón, Madrid, España
b Instituto de Investigación Biomédica del Hospital Gregorio Marañón, Madrid, España
c Reumatología e Inmunología, Universidad Friedrich-Alexander, Erlangen-Nürmberg, Alemania
Read
4747
Times
was read the article
2073
Total PDF
2674
Total HTML
Share statistics
 array:23 [
  "pii" => "S2173574318301424"
  "issn" => "21735743"
  "doi" => "10.1016/j.reumae.2018.08.003"
  "estado" => "S300"
  "fechaPublicacion" => "2018-11-01"
  "aid" => "100000"
  "copyright" => "Elsevier Espa&#241;a&#44; S&#46;L&#46;U&#46; and Sociedad Espa&#241;ola de Reumatolog&#237;a y Colegio Mexicano de Reumatolog&#237;a"
  "copyrightAnyo" => "2018"
  "documento" => "article"
  "crossmark" => 1
  "subdocumento" => "sco"
  "cita" => "Reumatol Clin. 2018;14:317-9"
  "abierto" => array:3 [
    "ES" => false
    "ES2" => false
    "LATM" => false
  ]
  "gratuito" => false
  "lecturas" => array:2 [
    "total" => 10
    "formatos" => array:2 [
      "HTML" => 6
      "PDF" => 4
    ]
  ]
  "Traduccion" => array:1 [
    "es" => array:19 [
      "pii" => "S1699258X18301840"
      "issn" => "1699258X"
      "doi" => "10.1016/j.reuma.2018.08.004"
      "estado" => "S300"
      "fechaPublicacion" => "2018-11-01"
      "aid" => "1266"
      "copyright" => "Elsevier Espa&#241;a&#44; S&#46;L&#46;U&#46; and Sociedad Espa&#241;ola de Reumatolog&#237;a y Colegio Mexicano de Reumatolog&#237;a"
      "documento" => "article"
      "crossmark" => 1
      "subdocumento" => "sco"
      "cita" => "Reumatol Clin. 2018;14:317-9"
      "abierto" => array:3 [
        "ES" => true
        "ES2" => true
        "LATM" => true
      ]
      "gratuito" => true
      "lecturas" => array:2 [
        "total" => 2629
        "formatos" => array:3 [
          "EPUB" => 78
          "HTML" => 2076
          "PDF" => 475
        ]
      ]
      "es" => array:10 [
        "idiomaDefecto" => true
        "cabecera" => "<span class="elsevierStyleTextfn">Editorial</span>"
        "titulo" => "Ni los anticuerpos antinucleares ni los anticuerpos dirigidos contra ant&#237;genos extra&#237;bles del n&#250;cleo son lo que sol&#237;an ser&#46; Un futuro cambio de nomenclatura y recomendaciones para su determinaci&#243;n en pr&#225;ctica cl&#237;nica habitual"
        "tienePdf" => "es"
        "tieneTextoCompleto" => "es"
        "paginas" => array:1 [
          0 => array:2 [
            "paginaInicial" => "317"
            "paginaFinal" => "319"
          ]
        ]
        "titulosAlternativos" => array:1 [
          "en" => array:1 [
            "titulo" => "Neither the anti-nuclear antibodies nor the anti-extractable nuclear antigens Are What They Used to Be&#46; A Future Change of Nomenclature"
          ]
        ]
        "contieneTextoCompleto" => array:1 [
          "es" => true
        ]
        "contienePdf" => array:1 [
          "es" => true
        ]
        "autores" => array:1 [
          0 => array:2 [
            "autoresLista" => "Diana Hern&#225;ndez-Fl&#243;rez, Lara Valor"
            "autores" => array:2 [
              0 => array:2 [
                "nombre" => "Diana"
                "apellidos" => "Hern&#225;ndez-Fl&#243;rez"
              ]
              1 => array:2 [
                "nombre" => "Lara"
                "apellidos" => "Valor"
              ]
            ]
          ]
        ]
      ]
      "idiomaDefecto" => "es"
      "Traduccion" => array:1 [
        "en" => array:9 [
          "pii" => "S2173574318301424"
          "doi" => "10.1016/j.reumae.2018.08.003"
          "estado" => "S300"
          "subdocumento" => ""
          "abierto" => array:3 [
            "ES" => false
            "ES2" => false
            "LATM" => false
          ]
          "gratuito" => false
          "lecturas" => array:1 [
            "total" => 0
          ]
          "idiomaDefecto" => "en"
          "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173574318301424?idApp=UINPBA00004M"
        ]
      ]
      "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1699258X18301840?idApp=UINPBA00004M"
      "url" => "/1699258X/0000001400000006/v2_201812110614/S1699258X18301840/v2_201812110614/es/main.assets"
    ]
  ]
  "itemSiguiente" => array:19 [
    "pii" => "S2173574318301205"
    "issn" => "21735743"
    "doi" => "10.1016/j.reumae.2017.08.004"
    "estado" => "S300"
    "fechaPublicacion" => "2018-11-01"
    "aid" => "1121"
    "copyright" => "Elsevier Espa&#241;a&#44; S&#46;L&#46;U&#46; and Sociedad Espa&#241;ola de Reumatolog&#237;a y Colegio Mexicano de Reumatolog&#237;a"
    "documento" => "article"
    "crossmark" => 1
    "subdocumento" => "fla"
    "cita" => "Reumatol Clin. 2018;14:320-33"
    "abierto" => array:3 [
      "ES" => false
      "ES2" => false
      "LATM" => false
    ]
    "gratuito" => false
    "lecturas" => array:2 [
      "total" => 7
      "formatos" => array:2 [
        "HTML" => 3
        "PDF" => 4
      ]
    ]
    "en" => array:13 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Special Article</span>"
      "titulo" => "Recommendations by the Spanish Society of Rheumatology on the Use of Biological Therapies in Axial Spondyloarthritis"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "tieneResumen" => array:2 [
        0 => "en"
        1 => "es"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "320"
          "paginaFinal" => "333"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "Recomendaciones de la Sociedad Espa&#241;ola de Reumatolog&#237;a sobre el uso de terapias biol&#243;gicas en espondiloartritis axial"
        ]
      ]
      "contieneResumen" => array:2 [
        "en" => true
        "es" => true
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:7 [
          "identificador" => "fig0005"
          "etiqueta" => "Fig&#46; 1"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr1.jpeg"
              "Alto" => 1900
              "Ancho" => 3167
              "Tamanyo" => 411728
            ]
          ]
          "descripcion" => array:1 [
            "en" => "<p id="spar0045" class="elsevierStyleSimplePara elsevierViewall">Treatment algorithm for axial spondyloarthritis&#46; ADA&#58; adalimumab&#59; NSAIDS&#58; nonsteroidal anti-inflammatory drugs&#59; anti-IL17&#58; interleukin 17 inhibitor&#59; anti-TNF&#58; tumour necrosis factor inhibitor&#59; ASDAS&#58; ASAS-endorsed disease activity score&#59; BASDAI&#58; Bath Ankylosing Spondylitis Disease Activity Index&#59; DMARDs&#58; disease-modifying antirheumatic drugs&#59; GOL&#58; golimumab&#59; INF&#58; infliximab&#59; LF&#58; leflunomide&#59; MTX&#58; methotrexate&#59; SSZ&#58; sulfasalazine&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Jordi Gratac&#243;s, Petra D&#237;az del Campo Fontecha, Cristina Fern&#225;ndez-Carballido, Xavier Juanola Roura, Luis Francisco Linares Ferrando, Eugenio de Miguel Mendieta, Santiago Mu&#241;oz Fern&#225;ndez, Jose Luis Rosales-Alexander, Pedro Zarco Montejo, Mercedes Guerra Rodr&#237;guez, Victoria Navarro Comp&#225;n"
          "autores" => array:11 [
            0 => array:2 [
              "nombre" => "Jordi"
              "apellidos" => "Gratac&#243;s"
            ]
            1 => array:2 [
              "nombre" => "Petra"
              "apellidos" => "D&#237;az del Campo Fontecha"
            ]
            2 => array:2 [
              "nombre" => "Cristina"
              "apellidos" => "Fern&#225;ndez-Carballido"
            ]
            3 => array:2 [
              "nombre" => "Xavier"
              "apellidos" => "Juanola Roura"
            ]
            4 => array:2 [
              "nombre" => "Luis Francisco"
              "apellidos" => "Linares Ferrando"
            ]
            5 => array:2 [
              "nombre" => "Eugenio"
              "apellidos" => "de Miguel Mendieta"
            ]
            6 => array:2 [
              "nombre" => "Santiago"
              "apellidos" => "Mu&#241;oz Fern&#225;ndez"
            ]
            7 => array:2 [
              "nombre" => "Jose Luis"
              "apellidos" => "Rosales-Alexander"
            ]
            8 => array:2 [
              "nombre" => "Pedro"
              "apellidos" => "Zarco Montejo"
            ]
            9 => array:2 [
              "nombre" => "Mercedes"
              "apellidos" => "Guerra Rodr&#237;guez"
            ]
            10 => array:2 [
              "nombre" => "Victoria"
              "apellidos" => "Navarro Comp&#225;n"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "es" => array:9 [
        "pii" => "S1699258X17302322"
        "doi" => "10.1016/j.reuma.2017.08.008"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "es"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1699258X17302322?idApp=UINPBA00004M"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173574318301205?idApp=UINPBA00004M"
    "url" => "/21735743/0000001400000006/v1_201810310644/S2173574318301205/v1_201810310644/en/main.assets"
  ]
  "en" => array:14 [
    "idiomaDefecto" => true
    "cabecera" => "<span class="elsevierStyleTextfn">Editorial</span>"
    "titulo" => "Neither the anti-nuclear antibodies nor the anti-extractable nuclear antigens Are What They Used to Be&#46; A Future Change of Nomenclature"
    "tieneTextoCompleto" => true
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "317"
        "paginaFinal" => "319"
      ]
    ]
    "autores" => array:1 [
      0 => array:4 [
        "autoresLista" => "Diana Hern&#225;ndez-Fl&#243;rez, Lara Valor"
        "autores" => array:2 [
          0 => array:3 [
            "nombre" => "Diana"
            "apellidos" => "Hern&#225;ndez-Fl&#243;rez"
            "referencia" => array:2 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
              1 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">b</span>"
                "identificador" => "aff0010"
              ]
            ]
          ]
          1 => array:4 [
            "nombre" => "Lara"
            "apellidos" => "Valor"
            "email" => array:1 [
              0 => "larissa&#46;valormendez&#64;uk-erlangen&#46;de"
            ]
            "referencia" => array:4 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
              1 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">b</span>"
                "identificador" => "aff0010"
              ]
              2 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">c</span>"
                "identificador" => "aff0015"
              ]
              3 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">&#42;</span>"
                "identificador" => "cor0005"
              ]
            ]
          ]
        ]
        "afiliaciones" => array:3 [
          0 => array:3 [
            "entidad" => "Servicio de Reumatolog&#237;a&#44; Hospital General Universitario Gregorio Mara&#241;&#243;n&#44; Madrid&#44; Espa&#241;a"
            "etiqueta" => "a"
            "identificador" => "aff0005"
          ]
          1 => array:3 [
            "entidad" => "Instituto de Investigaci&#243;n Biom&#233;dica del Hospital Gregorio Mara&#241;&#243;n&#44; Madrid&#44; Espa&#241;a"
            "etiqueta" => "b"
            "identificador" => "aff0010"
          ]
          2 => array:3 [
            "entidad" => "Reumatolog&#237;a e Inmunolog&#237;a&#44; Universidad Friedrich-Alexander&#44; Erlangen-N&#252;rmberg&#44; Alemania"
            "etiqueta" => "c"
            "identificador" => "aff0015"
          ]
        ]
        "correspondencia" => array:1 [
          0 => array:3 [
            "identificador" => "cor0005"
            "etiqueta" => "&#8270;"
            "correspondencia" => "Corresponding author&#46;"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "es" => array:1 [
        "titulo" => "Ni los anticuperpos antinucleares ni los anticuerpos dirigidos contra ant&#237;genos extra&#237;bles del n&#250;cleoson lo que sol&#237;an ser&#46; Un futuro cambio de nomenclatura y recomendaciones para su determinaci&#243;n en pr&#225;ctica cl&#237;nica habitual"
      ]
    ]
    "textoCompleto" => "<span class="elsevierStyleSections"><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0005">Antinuclear Antibodies</span><p id="par0005" class="elsevierStylePara elsevierViewall">Antinuclear antibodies &#40;ANA&#41; were described for the first time by Coons and Kaplan&#44;<a class="elsevierStyleCrossRef" href="#bib0085"><span class="elsevierStyleSup">1</span></a> and although it is not indicated by their name&#44; they include autoantibodies &#40;AAb&#41; directed against cytoplasmic structures and the cell wall&#44; which is to say that this is a term sustained by historic reasons for more than 60 years&#46; In the classification of positive ANA staining patterns detected by immunofluorescence &#40;IF&#41;&#44; nuclear patterns are reported as much as cytoplasmic and mitotic patterns&#46;<a class="elsevierStyleCrossRefs" href="#bib0095"><span class="elsevierStyleSup">3&#44;4</span></a></p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0010">Antibodies Directed Against Extractable Nuclear Antigens</span><p id="par0010" class="elsevierStylePara elsevierViewall">Antibodies directed against extractable nuclear antigens &#40;ENA&#41; were described in 1959 by Holman and Robbins&#44;<a class="elsevierStyleCrossRef" href="#bib0105"><span class="elsevierStyleSup">5</span></a> who with the utilization of saline solutions of low ionic strength extracted 4 protein antigens from the nucleus&#58; SSA&#47;Ro60&#44; SSB7La&#44; U1-ribonucleoprotein &#40;RNP&#41; and Smith &#40;Sm&#41;&#46;</p><p id="par0015" class="elsevierStylePara elsevierViewall">Over time&#44; this spectrum has grown and it is possible to detect AAb directed against other cytoplasmic or nuclear antigens and other cell compartments&#44; such as receptors of</p><p id="par0020" class="elsevierStylePara elsevierViewall">lamina B in the nuclear membrane&#44; histones&#44; other RNP and proteins that are expressed only when the cell is in mitosis &#40;Sp100&#44; Ku&#44; Mi-2&#44; cyclin&#44; Scl-70&#44; mitotic spindle&#44; centrioles and kinetochores&#41;&#46; This has benefited the introduction of multiple detection tests that vary depending on the company&#44; according to the technological platform and the AAb to be evaluated&#46;<a class="elsevierStyleCrossRefs" href="#bib0090"><span class="elsevierStyleSup">2&#44;3</span></a> At the present time&#44; AAb detection panels usually include nuclear antigens &#40;double-stranded DNA&#44; ENA&#41; and cytoplasm antigens &#40;ribosomal-P Jo-1&#46; In Spain&#44; there are at least 5 companies that offer platforms for specific antigens &#40;the so-called ENA profile&#41;&#44; which utilize diverse native proteins&#44; purified or human recombinant&#44; such as Ro60 kDa&#44; Ro52 kDa&#44; La&#44; U1-RNP&#44; Sm&#44; histones&#44; centromere-B&#44; Scl-70 and Jo-1&#46;</p></span><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0015">Methodology for the Determination of Antinuclear Antibodies and Antibodies Directed Against Extractable Nuclear Antigens</span><p id="par0025" class="elsevierStylePara elsevierViewall">In the majority of autoimmunity laboratories&#44; both ANA and ENA are detected by IF&#44; utilizing the laryngeal carcinoma Hep-2 cell line or one of its variants &#40;for example&#44; the Hep-2000 cell line&#41;&#44; and report a maximum dilution in which the antigen-antibody reaction is observable&#44; as is the IF staining pattern&#46; It is considered that ANA are positive from a dilution of 1&#58;80 in adults &#40;although some guidelines recommend that a dilution of 1&#58;160 is the inferior limit&#41; and&#44; in pediatrics&#44; they are positive at dilutions starting at 1&#58;10 or 1&#58;20&#46;<a class="elsevierStyleCrossRefs" href="#bib0095"><span class="elsevierStyleSup">3&#44;6&#8211;8</span></a> Subsequently&#44; there is a second determination to evaluate the specificity of AAb using techniques such immunoblotting or enzyme-linked immunosorbent assay &#40;ELISA&#41;&#46; Because of the wide variability among the multiple assay platforms being marketed&#44; it is indispensable to know the antigens that have been evaluated in each determination and information must be given about all of those utilized&#44; whether the results were negative or positive&#46;<a class="elsevierStyleCrossRefs" href="#bib0090"><span class="elsevierStyleSup">2&#44;3&#44;6</span></a></p><p id="par0030" class="elsevierStylePara elsevierViewall">These determination provide us with extremely valuable information&#44; given that AAb can develop years before the clinical manifestations of systemic lupus erythematosus&#44; Sj&#246;gren&#39;s syndrome&#44; scleroderma&#44; mixed connective tissue disease and idiopathic or inflammatory myopathies &#40;IIM&#41;&#46; The findings are potentially relevant in the achievement of the diagnosis and for establishing the prognosis&#44; the different forms of the clinical course and the eventual complications of these diseases&#46;<a class="elsevierStyleCrossRefs" href="#bib0115"><span class="elsevierStyleSup">7&#8211;10</span></a></p></span><span id="sec0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0020">New Autoantibodies and a New Nomenclature&#63;</span><p id="par0035" class="elsevierStylePara elsevierViewall">The use of the nomenclature for ANA and ENA is currently considered imprecise&#59; there are authors who refer to them as AAb directed against specific cell antigens&#44;<a class="elsevierStyleCrossRefs" href="#bib0110"><span class="elsevierStyleSup">6&#8211;8</span></a> and a change in the nomenclature is recommended&#46;<a class="elsevierStyleCrossRef" href="#bib0110"><span class="elsevierStyleSup">6</span></a> The consensus on standardization for the evaluation of AAb was developed by two groups&#58; the European Autoimmunity Standardization Initiative &#40;EASI&#41; and the International Union of Immunologic Societies&#47;World Health Organization&#47;Arthritis Foundation&#47;Centers for Disease Control and Prevention &#40;IUIS&#47;WHO&#47;AF&#47;CDC&#41;&#46; The result is the proposal of a change in the nomenclature and 25 recommendations for the harmonization of clinical and technical aspects of AAb determination&#44; resolve discrepancies in the detection methods and stress the importance of communication between clinical specialists and the laboratory&#46;<a class="elsevierStyleCrossRef" href="#bib0110"><span class="elsevierStyleSup">6</span></a></p><p id="par0040" class="elsevierStylePara elsevierViewall">However&#44; what is the sense of adapting ourselves to employing a new nomenclature when we are at ease with the one we already know&#63; In recent years&#44; we have found that the number of new AAb associated with specific clinical conditions has continued to grow&#44; a fact that means that we must be increasingly accurate when we refer to them&#46; We should stress that some of these new AAb that are specific for IIM&#44; such as anti-MDA5 &#40;anti-melanoma differentiation-associated gene 5&#41; antibodies and anti-HMGCR &#40;anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase&#41;&#44; are not associated with any IF pattern&#46;<a class="elsevierStyleCrossRefs" href="#bib0135"><span class="elsevierStyleSup">11&#44;12</span></a></p><p id="par0045" class="elsevierStylePara elsevierViewall">Anti-Ro antibodies constitute another valid example to illustrate this case&#58; the distinction between Ro52 and Ro60 was not defined until 1988&#44; and they differ in their intracellular localization&#46;<a class="elsevierStyleCrossRef" href="#bib0145"><span class="elsevierStyleSup">13</span></a> Anti-Ro60 antibodies have a fine speckled pattern in IF&#44; whereas anti-Ro52 have no defined nuclear staining pattern<a class="elsevierStyleCrossRef" href="#bib0150"><span class="elsevierStyleSup">14</span></a>&#58; would it not then be more useful&#44; in this case&#44; to say that they are specific antibodies&#63;</p><p id="par0050" class="elsevierStylePara elsevierViewall">On the other hand&#44; the cytoplasmic pattern according to IF is defined like any cytoplasmic staining in HEp-2 cells&#44; regardless of the positive or negative staining of the nuclei or mitotic cells&#44; with 5 main pattern subgroups&#58; 1&#41; fibrillary&#59; 2&#41; speckled&#59; 3&#41; mitochondrial&#47;reticular&#59; 4&#41; polar&#47;Golgi apparatus&#59; and 5&#41; bars&#47;rings&#46; All should be included in the laboratory report&#44; as well as the reactivity observed in the cytoplasm and the recognized cytoplasmic structure&#46;<a class="elsevierStyleCrossRefs" href="#bib0090"><span class="elsevierStyleSup">2&#8211;4</span></a> With this diversity&#44; it may be worthwhile to change the manner in which we refer to AAb rather than to continue to utilize the term ANA&#46;</p></span><span id="sec0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0025">The Special Case of Idiopathic Inflammatory Myopathies&#58; Increasingly More Specific Autoantibodies</span><p id="par0055" class="elsevierStylePara elsevierViewall">The formation of AAb has a cardinal role in the pathogenesis of IIM and they are markers that contribute to the diagnosis&#46; With the relatively recent description of new AAb that are specific for IIM&#44; it has been demonstrated that around 60&#37; of these patients have specific AAb&#44; such as anti-Jo-1&#44; anti-MDA5&#44; anti-HMGCR&#44; anti-Mi-2&#44; anti-TIF1 &#40;transcription intermediary factors-1&#41;&#44; anti-NXP2 &#40;nuclear matrix protein 2&#41;&#44; anti-SAE &#40;small ubiquitin-related modifier &#91;SUMO&#93;-activating enzyme&#41; and anti-SRP &#40;signal recognition particle&#41;&#46; At the present time&#44; it is considered that their detection during early phases would be useful in predicting the clinical course of the disease&#46;<a class="elsevierStyleCrossRefs" href="#bib0135"><span class="elsevierStyleSup">11&#44;12</span></a> It is important to point out that&#44; according to IF&#44; only some of these AAb were associated with a speckled or fine speckled cytoplasmic pattern&#59; others were not detected by means of IF&#44; but they were negative for ANA&#46;</p><p id="par0060" class="elsevierStylePara elsevierViewall">Due to the notable association between these AAb and the different clinical phenotypes&#44; it is postulated that they are important not only for the classifications of IIM&#44; but also as factors implicated in the mechanism that underlies their pathogenesis&#44; such as induction&#44; the perpetuation of muscle damage and the association between autoimmunity and oncogenesis&#46;<a class="elsevierStyleCrossRef" href="#bib0135"><span class="elsevierStyleSup">11</span></a> Among these&#44; anti-MDA5 has been related to certain phenotypes of dermatomyositis &#40;DM&#41;&#44; especially with clinically amyopathic DM and with a higher risk of rapidly progressive acute interstitial lung disease&#46;<a class="elsevierStyleCrossRefs" href="#bib0155"><span class="elsevierStyleSup">15&#44;16</span></a> Anti-MDA5 is mutually exclusive with respect to other representative AAb detected in DM&#44; in myopathy associated with cancer and in polymyositis&#46;<a class="elsevierStyleCrossRefs" href="#bib0135"><span class="elsevierStyleSup">11&#44;12&#44;15&#44;16</span></a></p></span><span id="sec0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0030">Perspectives</span><p id="par0065" class="elsevierStylePara elsevierViewall">It is quite clear that&#44; in the near future&#44; we will continue to utilize the nomenclature to which we are accustomed&#44; but it is worthwhile that we become familiar with the new proposals and adapt ourselves to them&#59; the changes may possibly come from laboratory reports as we advance in the description of new AAb&#46;</p><p id="par0070" class="elsevierStylePara elsevierViewall">Changes in nomenclature is not a new situation in rheumatology&#59; in 2012&#44; we saw that the comprehension of the clinical and pathological characteristics of systemic vasculitis made it necessary to modify existing concepts in the International Chapel Hill Consensus Conference that revised the nomenclature of vasculitides for the purpose of offering a more appropriate nomenclature&#46; We have gradually become adapted to this new nomenclature&#44; and it is now the one we utilize in routine clinical practice&#46;<a class="elsevierStyleCrossRef" href="#bib0165"><span class="elsevierStyleSup">17</span></a></p><p id="par0075" class="elsevierStylePara elsevierViewall">Therefore&#44; if the specificity of an AAb is capable of indicating the road toward a clearer definition of the clinical characteristics&#44; toward the prognosis and the outcome of certain conditions&#44; we should be more specific with the terminology&#46; This&#44; moreover&#44; could facilitate communication between clinicians and laboratory professionals&#44; as well as the design of new and more dynamic diagnostic algorithms&#46;</p></span></span>"
    "textoCompletoSecciones" => array:1 [
      "secciones" => array:8 [
        0 => array:2 [
          "identificador" => "sec0005"
          "titulo" => "Antinuclear Antibodies"
        ]
        1 => array:2 [
          "identificador" => "sec0010"
          "titulo" => "Antibodies Directed Against Extractable Nuclear Antigens"
        ]
        2 => array:2 [
          "identificador" => "sec0015"
          "titulo" => "Methodology for the Determination of Antinuclear Antibodies and Antibodies Directed Against Extractable Nuclear Antigens"
        ]
        3 => array:2 [
          "identificador" => "sec0020"
          "titulo" => "New Autoantibodies and a New Nomenclature&#63;"
        ]
        4 => array:2 [
          "identificador" => "sec0025"
          "titulo" => "The Special Case of Idiopathic Inflammatory Myopathies&#58; Increasingly More Specific Autoantibodies"
        ]
        5 => array:2 [
          "identificador" => "sec0030"
          "titulo" => "Perspectives"
        ]
        6 => array:2 [
          "identificador" => "xack374086"
          "titulo" => "Acknowledgments"
        ]
        7 => array:1 [
          "titulo" => "Bibliograf&#237;a"
        ]
      ]
    ]
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "NotaPie" => array:1 [
      0 => array:2 [
        "etiqueta" => "&#9734;"
        "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Please cite this article as&#58; Hern&#225;ndez-Fl&#243;rez D&#44; Valor L&#46; Ni los anticuperpos antinucleares ni los anticuerpos dirigidos contra ant&#237;genos extra&#237;bles del n&#250;cleoson lo que sol&#237;an ser&#46; Un futuro cambio de nomenclatura y recomendaciones para su determinaci&#243;n en pr&#225;ctica cl&#237;nica habitual&#46; Reumatol Clin&#46; 2018&#59;14&#58;317&#8211;319&#46;</p>"
      ]
    ]
    "bibliografia" => array:2 [
      "titulo" => "Bibliograf&#237;a"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "bibs0015"
          "bibliografiaReferencia" => array:17 [
            0 => array:3 [
              "identificador" => "bib0085"
              "etiqueta" => "1"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Localization of antigen in tissue cells&#59; improvements in a method for the detection of antigen by means of fluorescent antibody"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "A&#46;H&#46; Coons"
                            1 => "M&#46;H&#46; Kaplan"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "J Exp Med&#46;"
                        "fecha" => "1950"
                        "volumen" => "91"
                        "paginaInicial" => "1"
                        "paginaFinal" => "13"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15395569"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib0090"
              "etiqueta" => "2"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "International consensus on ANA patterns &#40;ICAP&#41;&#58; the bumpy road towards a consensus on reporting ANA results"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "J&#46; Damoiseaux"
                            1 => "C&#46;A&#46; von M&#252;hlen"
                            2 => "I&#46; Garcia-de la Torre"
                            3 => "O&#46;G&#46; Carballo"
                            4 => "W&#46; de Melo Cruvinel"
                            5 => "P&#46;L&#46;C&#46; Francescantonio"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1007/s13317-016-0075-0"
                      "Revista" => array:6 [
                        "tituloSerie" => "Auto Immun Highlights&#46;"
                        "fecha" => "2016"
                        "volumen" => "7"
                        "paginaInicial" => "1"
                        "paginaFinal" => "8"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26831867"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib0095"
              "etiqueta" => "3"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Challenges in the standardization of autoantibody testing&#58; a comprehensive review"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "R&#46; Tozzoli"
                            1 => "D&#46; Villalta"
                            2 => "N&#46; Bizzaro"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1007/s12016-016-8579-y"
                      "Revista" => array:6 [
                        "tituloSerie" => "Clin Rev Allergy Immunol&#46;"
                        "fecha" => "2017"
                        "volumen" => "53"
                        "paginaInicial" => "68"
                        "paginaFinal" => "77"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/27498835"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib0100"
              "etiqueta" => "4"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Report of the First International Consensus on Standardized Nomenclature of Antinuclear Antibody HEp-2 Cell Patterns 2014-2015"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "E&#46;K&#46; Chan"
                            1 => "J&#46; Damoiseaux"
                            2 => "O&#46;G&#46; Carballo"
                            3 => "K&#46; Conrad"
                            4 => "W&#46; de Melo Cruvinel"
                            5 => "P&#46;L&#46; Francescantonio"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.3389/fimmu.2015.00412"
                      "Revista" => array:5 [
                        "tituloSerie" => "Front Immunol&#46;"
                        "fecha" => "2015"
                        "volumen" => "6"
                        "paginaInicial" => "412"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26347739"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            4 => array:3 [
              "identificador" => "bib0105"
              "etiqueta" => "5"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Antinuclear antibodies in systemic lupus erythematosus"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "H&#46; Holman"
                            1 => "W&#46; Robbins"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Arthritis Rheum&#46;"
                        "fecha" => "1959"
                        "volumen" => "2"
                        "paginaInicial" => "468"
                        "paginaFinal" => "471"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/14402747"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            5 => array:3 [
              "identificador" => "bib0110"
              "etiqueta" => "6"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "N&#46; Agmon-Levin"
                            1 => "J&#46; Damoiseaux"
                            2 => "C&#46; Kallenberg"
                            3 => "U&#46; Sack"
                            4 => "T&#46; Witte"
                            5 => "M&#46; Herold"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1136/annrheumdis-2013-203863"
                      "Revista" => array:6 [
                        "tituloSerie" => "Ann Rheum Dis&#46;"
                        "fecha" => "2014"
                        "volumen" => "73"
                        "paginaInicial" => "17"
                        "paginaFinal" => "23"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24126457"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            6 => array:3 [
              "identificador" => "bib0115"
              "etiqueta" => "7"
              "referencia" => array:1 [
                0 => array:1 [
                  "referenciaCompleta" => "Wiik AS&#44; Hoier-Madsen M&#44; Forslid J&#44; et al&#46; Antinuclear antibodies&#58; a contemporary nomenclature using HEp-2 cells&#46; J Autoimmun 2010&#59;35&#58;276-90&#46;"
                ]
              ]
            ]
            7 => array:3 [
              "identificador" => "bib0120"
              "etiqueta" => "8"
              "referencia" => array:1 [
                0 => array:1 [
                  "referenciaCompleta" => "Meroni PL&#44; Schur PH&#46; ANA screening&#58; an old test with new recommendations&#46; Ann Rheum Dis&#46; 2010&#59;69&#58;1420-2&#46;"
                ]
              ]
            ]
            8 => array:3 [
              "identificador" => "bib0125"
              "etiqueta" => "9"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Development of autoantibodies before the clinical onset of systemic lupus erythematosus"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "M&#46;R&#46; Arbuckle"
                            1 => "M&#46;T&#46; McClain"
                            2 => "M&#46;V&#46; Rubertone"
                            3 => "R&#46;H&#46; Scofield"
                            4 => "G&#46;J&#46; Dennis"
                            5 => "J&#46;A&#46; James"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1056/NEJMoa021933"
                      "Revista" => array:6 [
                        "tituloSerie" => "N Engl J Med&#46;"
                        "fecha" => "2003"
                        "volumen" => "349"
                        "paginaInicial" => "1526"
                        "paginaFinal" => "1533"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/14561795"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            9 => array:3 [
              "identificador" => "bib0130"
              "etiqueta" => "10"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Autoantibodies predate the onset of systemic lupus erythematosus in northern Sweden"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "C&#46; Eriksson"
                            1 => "H&#46; Kokkonen"
                            2 => "M&#46; Johansson"
                            3 => "G&#46; Hallmans"
                            4 => "G&#46; Wadell"
                            5 => "S&#46; Rantap&#228;&#228;-Dahlqvist"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1186/ar3258"
                      "Revista" => array:5 [
                        "tituloSerie" => "Arthritis Res Ther&#46;"
                        "fecha" => "2011"
                        "volumen" => "13"
                        "paginaInicial" => "R30"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21342502"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            10 => array:3 [
              "identificador" => "bib0135"
              "etiqueta" => "11"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Autoantibodies in myositis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "N&#46; McHugh"
                            1 => "S&#46;L&#46; Tansley"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1038/nrrheum.2018.56"
                      "Revista" => array:6 [
                        "tituloSerie" => "Nat Rev Rheumatol&#46;"
                        "fecha" => "2018"
                        "volumen" => "14"
                        "paginaInicial" => "290"
                        "paginaFinal" => "302"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/29674612"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            11 => array:3 [
              "identificador" => "bib0140"
              "etiqueta" => "12"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Bench to bedside review of myositis autoantibodies"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "B&#46; Palterer"
                            1 => "G&#46; Vitiello"
                            2 => "A&#46; Carraresi"
                            3 => "M&#46;G&#46; Giudizi"
                            4 => "D&#46; Cammelli"
                            5 => "P&#46; Parronchi"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1186/1476-7961-7-5"
                      "Revista" => array:5 [
                        "tituloSerie" => "Clin Mol Allergy&#46;"
                        "fecha" => "2018"
                        "volumen" => "7"
                        "paginaInicial" => "5"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19284628"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            12 => array:3 [
              "identificador" => "bib0145"
              "etiqueta" => "13"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "A 52-kD protein is a novel component of the SS-A&#47;Ro antigenic particle"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "E&#46; Ben-Chetrit"
                            1 => "E&#46;K&#46;L&#46; Chan"
                            2 => "K&#46;F&#46; Sullivan"
                            3 => "E&#46;M&#46; Tan"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "J Exp Med&#46;"
                        "fecha" => "1988"
                        "volumen" => "167"
                        "paginaInicial" => "1560"
                        "paginaFinal" => "1571"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/3367095"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            13 => array:3 [
              "identificador" => "bib0150"
              "etiqueta" => "14"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Autoantibodies to 60kDa SS-A&#47;Ro yield a specific nuclear myriad discrete fine speckled immunofluorescence pattern"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "A&#46; Dellavance"
                            1 => "R&#46;R&#46; Alvarenga"
                            2 => "S&#46;H&#46; Rodrigues"
                            3 => "S&#46;H&#46; Barbosa"
                            4 => "A&#46;C&#46; Camilo"
                            5 => "H&#46;S&#46; Shiguedomi"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.jim.2013.01.006"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Immunol Methods&#46;"
                        "fecha" => "2013"
                        "volumen" => "390"
                        "paginaInicial" => "35"
                        "paginaFinal" => "40"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23357050"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            14 => array:3 [
              "identificador" => "bib0155"
              "etiqueta" => "15"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Prevalence and clinical significance of anti-MDA5 antibodies in European patients with polymyositis&#47;dermatomyositis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "A&#46; Ceribelli"
                            1 => "M&#46; Fredi"
                            2 => "M&#46; Taraborelli"
                            3 => "I&#46; Cavazzana"
                            4 => "A&#46; Tincani"
                            5 => "C&#46; Selmi"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Clin Exp Rheumatol&#46;"
                        "fecha" => "2014"
                        "volumen" => "32"
                        "paginaInicial" => "891"
                        "paginaFinal" => "897"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25151986"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            15 => array:3 [
              "identificador" => "bib0160"
              "etiqueta" => "16"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Anti-MDA5 antibodies in a large Mediterranean population of adults with dermatomyositis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "M&#46; Labrador-Horrillo"
                            1 => "M&#46;A&#46; Martinez"
                            2 => "A&#46; Selva-O&#8217;Callaghan"
                            3 => "E&#46; Trallero-Araguas"
                            4 => "E&#46; Balada"
                            5 => "M&#46; Vilardell-Tarres"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1155/2014/290797"
                      "Revista" => array:5 [
                        "tituloSerie" => "J Immunol Res&#46;"
                        "fecha" => "2014"
                        "volumen" => "2014"
                        "paginaInicial" => "290797"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24741583"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            16 => array:3 [
              "identificador" => "bib0165"
              "etiqueta" => "17"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "J&#46;C&#46; Jennette"
                            1 => "R&#46;J&#46; Falk"
                            2 => "P&#46;A&#46; Bacon"
                            3 => "N&#46; Basu"
                            4 => "M&#46;C&#46; Cid"
                            5 => "F&#46; Ferrario"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1002/art.37715"
                      "Revista" => array:6 [
                        "tituloSerie" => "Arthritis Rheum&#46;"
                        "fecha" => "2013"
                        "volumen" => "65"
                        "paginaInicial" => "1"
                        "paginaFinal" => "11"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23045170"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
    "agradecimientos" => array:1 [
      0 => array:4 [
        "identificador" => "xack374086"
        "titulo" => "Acknowledgments"
        "texto" => "<p id="par0080" class="elsevierStylePara elsevierViewall">The authors wish to thank Dr&#46; Lina Mart&#237;nez-Estupi&#241;&#225;n &#40;Department of Rheumatology&#44; Fundaci&#243;n Jim&#233;nez D&#237;az&#44; Madrid&#41; and Dr&#46; Francisco Javier L&#243;pez-Longo &#40;Department of Rheumatology&#44; Hospital General Universitario Gregorio Mara&#241;&#243;n&#44; Madrid&#41; for their critical reading of this paper and the corrections they proposed&#46;</p>"
        "vista" => "all"
      ]
    ]
  ]
  "idiomaDefecto" => "en"
  "url" => "/21735743/0000001400000006/v1_201810310644/S2173574318301424/v1_201810310644/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "17335"
    "tipo" => "SECCION"
    "es" => array:2 [
      "titulo" => "Editorial"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "es"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/21735743/0000001400000006/v1_201810310644/S2173574318301424/v1_201810310644/en/main.pdf?idApp=UINPBA00004M&text.app=https://reumatologiaclinica.org/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173574318301424?idApp=UINPBA00004M"
]
Article information
ISSN: 21735743
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2024 October 62 38 100
2024 September 52 32 84
2024 August 67 48 115
2024 July 43 27 70
2024 June 43 37 80
2024 May 51 39 90
2024 April 71 34 105
2024 March 53 45 98
2024 February 89 36 125
2024 January 33 28 61
2023 December 22 30 52
2023 November 36 40 76
2023 October 29 46 75
2023 September 120 41 161
2023 August 36 25 61
2023 July 26 38 64
2023 June 27 28 55
2023 May 37 30 67
2023 April 25 11 36
2023 March 67 38 105
2023 February 58 33 91
2023 January 26 20 46
2022 December 72 38 110
2022 November 53 52 105
2022 October 67 31 98
2022 September 60 42 102
2022 August 67 44 111
2022 July 55 46 101
2022 June 51 39 90
2022 May 51 47 98
2022 April 46 39 85
2022 March 48 34 82
2022 February 36 38 74
2022 January 54 47 101
2021 December 35 37 72
2021 November 36 57 93
2021 October 64 63 127
2021 September 33 52 85
2021 August 24 66 90
2021 July 22 25 47
2021 June 29 27 56
2021 May 57 46 103
2021 April 134 112 246
2021 March 68 41 109
2021 February 66 18 84
2021 January 34 25 59
2020 December 58 23 81
2020 November 50 44 94
2020 October 39 16 55
2020 September 38 32 70
2020 August 25 29 54
2020 July 23 30 53
2020 June 25 25 50
2020 May 35 32 67
2020 April 26 17 43
2020 March 14 11 25
2019 November 1 2 3
2019 June 3 2 5
2018 December 1 0 1
2018 November 1 0 1
Show all

Follow this link to access the full text of the article

Idiomas
Reumatología Clínica (English Edition)
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?